Factual end-of-day data for EMCURE: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 74,864 shares was well below the 20-day average (0.5×).
EMCURE's delivery share of 62.1% was above its 20-day average of 56.0%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 43.9 |
| 50-day EMA | ₹1,862.45 — close is below |
| 200-day EMA | ₹1,670.54 — close is above |
| SuperTrend (10, 3) | ₹1,838.09 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
EMCURE is a large-cap NSE stock in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹27,271 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 62.1% of EMCURE's traded volume was marked for delivery (46,461 shares delivered). The 20-day average delivery is 56.0%.
EMCURE closed at ₹1,862.30 on 26 Aug 2026 (+0.83% vs the previous close).
52-week high ₹2,048.00, 52-week low ₹1,260.00. The latest close is -9.07% from the 52-week high.